Cargando…
Finding new therapies for sepsis: the need for patient stratification and the use of genetic biomarkers
Reversing the immunoparalysis associated with septic shock remains a priority for improving the outcome of patients suffering from sepsis. The efficacy of future therapies may be better studied under an effective system of patient stratification. Gene expression biomarkers offer a mechanism by which...
Autores principales: | Hobson, Michael J, Wong, Hector R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388659/ https://www.ncbi.nlm.nih.gov/pubmed/22169064 http://dx.doi.org/10.1186/cc10527 |
Ejemplares similares
-
PIRO and sepsis stratification: reality or a mirage?
por: Granj a, Cristina, et al.
Publicado: (2015) -
Apolipoprotein M - a new biomarker in sepsis
por: Christoffersen, Christina, et al.
Publicado: (2012) -
PSP/reg: a new stone in sepsis biomarkers?
por: Busani, Stefano, et al.
Publicado: (2012) -
Understanding genetics of sepsis: will new technology help?
por: Yende, Sachin, et al.
Publicado: (2009) -
Predicting outcome in patients with sepsis: new biomarkers for old expectations
por: Charles, Pierre-Emmanuel, et al.
Publicado: (2014)